about
Prevalence of anti-RNA polymerase III antibodies in systemic sclerosis: New data from a French cohort and a systematic review and meta-analysis[Pseudo-adult Still's disease, anasarca, thrombotic thrombocytopenic purpura and dysautonomia: An atypical presentation of multicentric Castleman's disease. Discussion of TAFRO syndrome].Risk factors for severe bacterial infections in patients with systemic autoimmune diseases receiving rituximab.Relevance of partitioning DLCO to detect pulmonary hypertension in systemic sclerosisMyocarditis in Patients With Antisynthetase Syndrome: Prevalence, Presentation, and Outcomes.Outcome of hepatitis E virus infection in patients with inflammatory arthritides treated with immunosuppressants: a French retrospective multicenter study.In antisynthetase syndrome, ACPA are associated with severe and erosive arthritis: an overlapping rheumatoid arthritis and antisynthetase syndrome.Digestive-tract sarcoidosis: French nationwide case-control study of 25 casesB Cell Homeostasis and Functional Properties Are Altered in an Hypochlorous Acid-Induced Murine Model of Systemic Sclerosis.Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis.Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies.IL-18 Is Involved in Eosinophil-Mediated Tumoricidal Activity against a Colon Carcinoma Cell Line by Upregulating LFA-1 and ICAM-1.Long term use of metformin in idiopathic cyclic edema, report of thirteen cases and review of the literature.Role of B cells in the pathogenesis of systemic sclerosis.Diagnosis of primary antibody and complement deficiencies in young adults after a first invasive bacterial infection.Tocilizumab in Giant Cell Arteritis: A Multicenter Retrospective Study of 34 Patients.(A Critical Appraisal of) Classification of Hypereosinophilic Disorders.Proinflammatory B-cell profile in the early phases of MS predicts an active disease.Pernicious anemia presenting as catatonia: correlating vitamin B12 levels and catatonic symptoms.Altered B lymphocyte homeostasis and functions in systemic sclerosis.Value of the Overall Pneumococcal Polysaccharide Response in the Diagnosis of Primary Humoral Immunodeficiencies.Successful Heart Transplantation for Unreversible Endomyocardial Fibrosis Related to FIP1L1-PDGFRA Chronic Eosinophilic Leukemia.Reply to Gilchrist et al. and to MusherHaemodynamically proven pulmonary hypertension in a patient with GATA2 deficiency-associated pulmonary alveolar proteinosis and fibrosisSeronegative polyarthritis revealing antisynthetase syndrome: a multicentre study of 40 patientsSerum free light chains of immunoglobulins as biomarkers for systemic sclerosis characteristics, activity and severityUne gastrite atypiqueNeurolupus (1re partie). Description et démarche diagnostique et thérapeutique dans les manifestations neurologiques centrales et psychiatriques au cours du lupus érythémateux systémiqueNeurolupus (2e partie). Description des outils diagnostiques et thérapeutiques devant une manifestation psychiatrique ou neurologique centrale au cours du lupus érythémateux systémiqueTout part de Greenwich…Thrombotic events during long-term follow-up of obstetric antiphospholipid syndrome patientsSubcutaneous Immunoglobulin Therapy Prevents Systemic Capillary Leak Syndrome AttackImmunoglobulin G (IgG) and IgG subclass reference intervals in children, using Optilite® reagents[Renal extramedullary hematopoietic tumor revealing a hereditary spherocytosis in an adult patient]Alopecia induced by tumour necrosis factor-alpha antagonists: description of 52 cases and disproportionality analysis in a nationwide pharmacovigilance database[A particular immune deficiency]Hypereosinophilia with asthma and systemic (non-vasculitic) manifestations: Eosinophilic granulomatosis with polyangiitis or hypereosinophilic syndrome?
P50
Q27000819-D000530D-D958-4E82-BF67-CCE58964C607Q33426263-69DE8C40-CF07-4933-A190-D09B3C27B716Q33757203-98FB20EE-8850-4A5C-9FCC-92D56E468039Q35035897-F8D7A2BD-1227-44A7-95AD-C3F9B7E3ABF4Q35857842-16B862F8-9044-47B2-A50E-DA567249090EQ36009254-CC606686-167F-4E9F-89D9-4C88561E277BQ36152934-C367C466-D2E1-47D7-AB92-25769DAC80AAQ37605477-3DCBFD49-E478-42A3-A89C-B013E862E069Q37627201-607EF58F-66DF-45D2-A2DE-6F3E6FF7516AQ38112387-5B123393-B193-4038-A75E-7EFF666FBCF7Q38280730-4C60A604-E02B-452F-A0A8-3826BBE57A15Q38848742-876375FA-F42F-4167-AFB6-DD7D9F7743DDQ39141148-2F2FF438-4AEF-428F-BB96-618D8FF53F9CQ39884656-E738A68B-4898-423E-8E90-67D45475FA47Q40335052-7361A5FE-37AA-437F-AF0C-CCA75036FA01Q40752982-C812EF3F-6188-4031-B784-2643DB4002FDQ47094850-84657EBB-B031-44AE-A57B-9F80F1223E92Q47108737-5662DA6A-1806-40CE-A2BC-6D22DD6441E2Q48095728-5080C9D3-AFEC-4F0E-9F56-F32198CDC648Q49990679-C48B4D16-F867-4868-8068-0D02AB568801Q50075629-E83DC774-6B3E-45AD-87C5-56A0B21C51FAQ52907888-EF85FE8D-1DCC-4BBC-BE13-A981DF34EDFDQ56977542-4D065411-7FE1-4AEF-B56E-C6148CB73F6DQ56977596-377AB6A4-36F2-4749-BC0C-254FA2BD5751Q56977794-86460B21-052D-454A-8B2F-93B76EB08609Q56977854-561DF3C4-3F4E-47DC-AD79-3D4D56EBDD33Q56977880-936A55ED-1593-4B74-ABEB-FB6F6D36E2B4Q56977951-18B1B039-2BB3-42CE-B993-0430AE7239E2Q56977955-0221C62F-A420-4F6C-83B9-F7E7D662E8CBQ56977992-CE9C158D-64CB-49E9-86CF-479C4E672279Q56978037-1C5B18AE-7C5E-4368-8D2A-8D98D68E1CA5Q57612734-EFAE5A87-9A7D-4FAC-AD1E-C05FEA02C404Q59412990-899491F5-36A9-4119-B4F2-292D4909FE95Q86968755-1C888EEF-27AD-4CE5-8654-2A7DAE8A716CQ87556962-B0E02B58-677A-4648-83CF-12250FF55B34Q88558280-E5979E79-8AFE-4A72-B5A9-FE5D49C49F0EQ88900458-C9CA2F5A-3337-4F4B-B0F7-94454BF41C1A
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Guillaume Lefevre
@ast
Guillaume Lefevre
@en
Guillaume Lefevre
@es
Guillaume Lefevre
@nl
type
label
Guillaume Lefevre
@ast
Guillaume Lefevre
@en
Guillaume Lefevre
@es
Guillaume Lefevre
@nl
prefLabel
Guillaume Lefevre
@ast
Guillaume Lefevre
@en
Guillaume Lefevre
@es
Guillaume Lefevre
@nl
P106
P31
P496
0000-0002-9427-7267